日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Letter re: Global advances and future directions in lung cancer care: expert consensus and strategic priorities

关于“肺癌治疗的全球进展和未来方向：专家共识和战略重点”的来信

期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2026.106906
Escriu, C
肺癌
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer

奥希替尼新辅助治疗可切除的EGFR突变型非小细胞肺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO-25-00883
He, Jianxing; Tsuboi, Masahiro; Weder, Walter; Chen, Ke-Neng; Hochmair, Maximilian J; Shih, Jin-Yuan; Lee, Sung Yong; Lee, Kang-Yun; Nhung, Nguyen Viet; Saeteng, Somcharoen; Liu, Lunxu; Xing, Ligang; Gia, Nguyen Hoang; Murakami, Shuji; Han, Yongtao; Saavedra, María Paz; Yoon, Seong Hoon; Teixeira, Carlos H A; Escriu, Carles; Martinez-Marti, Alex; Blakely, Collin M; Yatabe, Yasushi; Dacic, Sanja; Rukazenkov, Yuri; Huang, Xiangning; Dayal, Anupriya; Chaft, Jamie E
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Intracranial Efficacy of Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in Real-World Patients with Non-Small-Cell Lung Cancer and EGFR or ALK Alterations

阿特珠单抗、贝伐珠单抗、卡铂和紫杉醇在真实世界中伴有EGFR或ALK改变的非小细胞肺癌患者中的颅内疗效

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers16071249
Rathbone, Marcus; O'Hagan, Conor; Wong, Helen; Khan, Adeel; Cook, Timothy; Rose, Sarah; Heseltine, Jonathan; Escriu, Carles
肺癌
肿瘤
肿瘤免疫
ALK
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Efficacy of carboplatin-etoposide rechallenge after first-line chemo-immunotherapy in ES-SCLC: an international multicentric analysis

一线化疗联合免疫治疗后，卡铂-依托泊苷再次治疗在广泛期小细胞肺癌中的疗效：一项国际多中心分析

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241272957
Gomez-Randulfe, Igor; Silva Díaz, Sofía; Escriu, Carles; Mohammed, Saara; Shah, Riyaz; Benitez Fuentes, Javier David; Cox, Samantha; Monaca, Federico; Bria, Emilio; García-Campelo, María Rosario; Crook, Benjamin; Talbot, Toby; Leporati, Rita; Balachandran, Kirsty; Newsom-Davis, Tom; Hughes, Sarah; Cove-Smith, Laura; Taylor, Paul; Blackhall, Fiona; Califano, Raffaele
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

真实世界中接受化疗联合免疫治疗的晚期非小细胞肺癌患者的免疫治疗相关不良事件：Spinnaker 研究的亚组分析

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1163768
Anpalakhan, Shobana; Huddar, Prerana; Behrouzi, Roya; Signori, Alessio; Cave, Judith; Comins, Charles; Cortellini, Alessio; Addeo, Alfredo; Escriu, Carles; McKenzie, Hayley; Barone, Gloria; Murray, Lisa; Pinato, David J; Ottensmeier, Christian; Campos, Sara; Muthuramalingam, Sethupathi; Chan, Samuel; Gomes, Fabio; Banna, Giuseppe L
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Retrospective analysis of real-world treatment patterns and clinical outcomes in patients with advanced non-small cell lung cancer starting first-line systemic therapy in the United Kingdom

对英国接受一线全身治疗的晚期非小细胞肺癌患者的真实世界治疗模式和临床结果进行回顾性分析

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-021-08096-w
Lester, Jason; Escriu, Carles; Khan, Sarah; Hudson, Emma; Mansy, Talal; Conn, Andrew; Chan, Samuel; Powell, Ceri; Brock, Juliet; Conibear, John; Nelless, Lauren; Nayar, Vaneet; Zhuo, Xiaohui; Durand, Adeline; Amin, Amerah; Martin, Peter; Zhang, Xinke; Pawar, Vivek
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for EGFR-mutated resectable non-small-cell lung cancer: NeoADAURA

新辅助奥希替尼联合/不联合化疗与单纯化疗治疗EGFR突变型可切除非小细胞肺癌的疗效比较：NeoADAURA研究

期刊:Future Oncology
影响因子:2.6
doi:10.2217/fon-2021-0549
Tsuboi, Masahiro; Weder, Walter; Escriu, Carles; Blakely, Collin; He, Jianxing; Dacic, Sanja; Yatabe, Yasushi; Zeng, Lingmin; Walding, Andrew; Chaft, Jamie E
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
ADA
发表日期：2021
文献求助 收藏

Liquid biopsy mutation panel for non-small cell lung cancer: analytical validation and clinical concordance

非小细胞肺癌液体活检突变谱：分析验证和临床一致性

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-020-0118-x
Schwartzberg, Lee S; Horinouchi, Hidehito; Chan, David; Chernilo, Sara; Tsai, Michaela L; Isla, Dolores; Escriu, Carles; Bennett, John P; Clark-Langone, Kim; Svedman, Christer; Tomasini, Pascale
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2020
文献求助 收藏

A reciprocal feedback between the PDZ binding kinase and androgen receptor drives prostate cancer

PDZ 结合激酶和雄激素受体之间的相互反馈驱动前列腺癌

期刊:Oncogene
影响因子:6.9
doi:10.1038/s41388-018-0501-z
Anne Y Warren, Charlie E Massie, Kate Watt, Katarina Luko, Folake Orafidiya, Luke A Selth, Hisham Mohammed, Brinder S Chohan, Suraj Menon, Ajoeb Baridi, Wanfeng Zhao, Carles Escriu, Thanakorn Pungsrinont, Clive D'Santos, Xiaoping Yang, Chris Taylor, Arham Qureshi, Vincent R Zecchini, Greg L Shaw, Sc
肿瘤
前列腺癌
发表日期：2019
文献求助 收藏

Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network

真实世界中，IV期小细胞肺癌患者接受四周期一线铂类和依托泊苷化疗后的后续治疗：默西塞德郡和柴郡癌症网络的回顾性研究

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-019-0948-x
Sallam, Mostafa; Wong, Helen; Escriu, Carles
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏